Since BPC-157 is not an approved therapeutic agent in any country, there is no basis for granting a TUE for this substance
Sources: The actin binding site on thymosin beta-4 promotes angiogenesis Thymosin beta-4: A novel corneal wound healing and anti-inflammatory peptide Biological activities of thymosin beta-4 defined by active sites in short peptide sequences Progress on the Function and Application of Thymosin 4 Thymosin Beta 4: A Potential Novel Adjunct Treatment for Severe Coronavirus Disease 2019 The product is intended for scientific research and laboratory analysis
(2004), Abu-Elheiga et al
Some cytokines, such as TNF- and TGF-, increase mucin secretion through the interaction of the EGFR and reactive oxygen species pathways as well as generation of small nucleotides which trigger mucin granule exocytosis such as cyclic-di-GMP, ATP, or cAMP (Perez-Vilar et al., 2005
What shortens sealed-vial shelf life: Sustained heat above 30C
"Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." HSS Journal , 21, 485495